Sotac Pharmaceuticals Ltd
SOTAC
Company Profile
Business description
Sotac Pharmaceuticals Ltd is a pharma manufacturer, specializing in the manufacturing of a wide range of pharmaceutical products such as Non-Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non-Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray, and cream.
Contact
Plot No. PF-21, Near ACME Pharma
Opposite Teva Pharma Sanand GIDC-II
Sanand
AhmedabadGJ382110
INDT: +91 9913562852
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
68
Stocks News & Analysis
stocks
We take a different view to market on ASX bloodbath
Sales growth at CSL was lower than expected but streamlining the business has its perks.
stocks
BHP earnings weaker with lower iron ore prices more than offsetting higher copper volumes
Results were softer than expected.
stocks
Moated ASX player makes moves to support growth in China
a2Milk announced an acquisition and a divestiture as it aims to take a bigger slice of China’s baby formula market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,173.80 | 59.70 | -0.65% |
| CAC 40 | 7,979.08 | 95.03 | 1.21% |
| DAX 40 | 24,423.07 | 108.30 | 0.45% |
| Dow JONES (US) | 44,922.27 | 10.45 | 0.02% |
| FTSE 100 | 9,189.22 | 31.48 | 0.34% |
| HKSE | 25,122.90 | 53.95 | -0.21% |
| NASDAQ | 21,314.95 | 314.82 | -1.46% |
| Nikkei 225 | 43,546.29 | 168.02 | -0.38% |
| NZX 50 Index | 12,938.63 | 9.95 | 0.08% |
| S&P 500 | 6,411.37 | 37.78 | -0.59% |
| S&P/ASX 200 | 8,896.20 | 63.10 | -0.70% |
| SSE Composite Index | 3,727.29 | 0.74 | -0.02% |